My Portfolio May22

 

Summary of May 2022

Stock Portfolio @ End of May22

Since reaching its height in Feb22, my stock portfolio value has been gradually shrinking non-stop like a leaking pipe.

May is the worst month to my portfolio so far this year with a loss of 4.2%. The main culprit is the 17% decline of Maybulk while most tech-related stocks also suffered in this month.

Year-to-date loss stands at 9% but it's still better than year 2016 & 2018 which suffered loss of 14.7% and 13.5% respectively at this stage.

There seems to be nothing special happening in May, just the old stories of inflation, US rate hike and Russia-Ukraine war. 

Brent oil price continues its uptrend and it touched USD124/bbl in the last day of May.

From the financial performance of local listed companies, I feel that most of them do not do very well.

For those companies in my portfolio, I think the latest quarterly results of Uchitec, MFCB, Rhonema, JHM, Master and LEESK are good. 

The rest are so-so.

Rhonema: Milk Not Enough

 

Rhonema was listed on the main market of Bursa in December 2016 at an issue price of 75sen.

It is mainly involved in manufacturing and distribution of animal health products to livestock industry, as well as distribution and supply of food ingredients to food manufacturers.

The animal health products include pharmaceuticals, vaccines, feed & feed additives etc, are mainly for the poultry & swine segment. 

In early 2020, the company expanded into the ruminant segment (cow) by acquiring 49% stake in 3 companies.

This acquisition includes a small dairy farming business which produces fresh milk which is sold to wholesalers.

Rhonema mentioned that it has a plan to grow this dairy farming business and did not rule out venturing downstream to have its own brand of fresh milk products in the future.

That's one of the main reasons I decided to invest in Rhonema.

My Portfolio May21

Summary For May 2021

Portfolio @ End of May21

Due to the slump in SCIB share price, my portfolio suffers its heaviest loss in one month at -19% since losing 21.7% in Mac20. 

SCIB was my major holding and made up ~40% of my portfolio. It has contributed massively to my portfolio gain this year but now I have to vomit out those gain.

The big news in the stock market in May should be none other than Serba Dinamik's audit issue.

Serbadk first announced its intention to appoint an independent firm to commence a special independent review on its accounting matters raised by external auditor KPMG on 25th May 2021.

It's then followed by a public holiday, 2 days of trading suspension and 2 days of weekend. 

When trading resumed on the 31 May, its share price straight away limited down.